Table 6. Independent predictors for favorable neurological outcome by multiple logistic regression analysis.
Covariate | Odds Ratio | 95% Confidence Interval of Odds Ratio | p Value |
---|---|---|---|
S100B difference (pg/mL) | 0.998 | 0.996–1.0000 | 0.0447 |
6.546 >VCAM at ROSC (ln ng/mL) >5.660a | 93.524 | 3.7950–2304.7773 | 0.0055 |
MPO at ROSC to the 0.25 power (ng/mL)b | 0.433 | 0.197–0.763 | 0.0127 |
Age (year) | 0.836 | 0.718–0.923 | 0.0040 |
APACHE II | 0.827 | 0.683–0.999 | 0.0497 |
a6.546> VCAM at ROSC (ln ng/mL) >5.660: natural logarithm of serum VCAM level at ROSC >5.669 and <6.546
bMPO at ROSC to the 0.25 power: serum MPO level at ROSC to the 0.25 power
Goodness-of-fit assessment: adjusted generalized R2 (Nagelkerke’s R2) = 0.667 > 0.3, the estimated area under the Receiver Operating Characteristic (ROC) curve = 0.938 > 0.7 (95% CI: 0.854–1), and the modified Hosmer and Lemeshow goodness-of-fit F test p = 0.0857 > 0.05 (df = 9, 55), which all indicated an excellent fit.